Pay in 4 interest-free payments of $5.55 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
Nature 575 (7784), 693698
The LEADER study 34 , found that the administration of liraglutide in diabetic patients was associated with a significant reduction in the incidence of nephropathy as a microvascular event compared to the placebo group (HR 0.78
or 27 or higher (defined as overweight) and a weight-related health condition (such as high blood pressure, high cholesterol, or type 2 diabetes)
I may be a signal
US$ 27.39
US$ 24.63
US$ 27.91
US$ 28.81
US$ 28.78
